ERG evaluation of daily, high-dose sildenafil usage

Documenta Ophthalmologica

Volumn 118, Issue 3, 2009, Pages 225-231

  Zoumalan, Christopher I ^a   Zamanian, Roham T ^a   Doyle, Ramona L ^a   Marmor, Michael F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Electroretinogram; Multifocal electroretinogram; Pulmonary hypertension; Sildenafil; Viagra

Indexed keywords

HYDROXYCHLOROQUINE; SILDENAFIL;

ADULT; ARTICLE; B WAVE; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; COLOR VISION; DRUG MEGADOSE; ELECTRORETINOGRAPHY; FEMALE; HUMAN; MALE; PULMONARY HYPERTENSION; RETINA CONE; RHEUMATOID ARTHRITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; COLOR VISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTRORETINOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PIPERAZINES; PURINES; REACTION TIME; RETINAL CONE PHOTORECEPTOR CELLS; SULFONES; VASODILATOR AGENTS; VISION, OCULAR;

EID: 67349224350     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-008-9148-3     Document Type: Article

References (17)

1. Goldstein I, Lue TF, Padma-Nathan H et al (1998) Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 338:1397-1404
2. Egan R, Pomeranz H (2000) Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 118:291-292
3. Pomeranz HD, Smith KH, Hart WM Jr et al (2002) Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 109:584-587
4. Jägle H, Jägle C, Serey L, Sharpe LT (2005) Dose-dependency and time-course of electrophysiologic short-term effects of VIAGRA: A case study. Doc Ophthalmol 110:247-254
5. Jagle H, Jagle C, Serey L et al (2004) Visual short-term effects of Viagra: Double-blind study in healthy young subjects. Am J Ophthalmol 137:842-849
6. Luu JK, Chappelow AV, McCulley TJ et al (2001) Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram. Am J Ophthalmol 132:388-394
7. Galie N, Ghofrani HA, Torbicki A et al (2005) Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353:2148-2157
8. Fries R, Shariat K, von Wilmowsky H et al (2005) Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation 112:2980-2985
9. Sairam K, Kulinskaya E, McNicholas TA et al (2002) Sildenafil influences lower urinary tract symptoms. BJU Int 90:836-839
10. Marmor MF, Holder GE, Seeliger MW et al (2004) Standard for clinical electroretinography (2004 update). Doc Ophthalmol 108:107-114
11. Hood DC, Bach M, Brigell M et al (2008) ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol 116:1-11
12. D'Alonzo GE, Barst RJ, Ayres SM et al (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343-349
13. O'Callaghan D, Gaine SP (2007) Combination therapy and new types of agents for pulmonary arterial hypertension. Clin Chest Med 28:169-185, ix
14. Estrade M, Grondin P, Cluzel J et al (1998) Effect of a cGMP-specific phosphodiesterase inhibitor on retinal function. Eur J Pharmacol 352:157-163
15. Danciger M, Blaney J, Gao YQ et al (1995) Mutations in the PDE6B gene in autosomal recessive retinitis pigmentosa. Genomics 30:1-7
16. Farber DB, Lolley RN (1974) Cyclic guanosine monophosphate: Elevation in degenerating photoreceptor cells of the C3H mouse retina. Science 186:449-451
17. McCullough AR, Steidle CP, Klee B, Tseng L-J (2008) Randomized, double-blind, crossover trial of sildenafil in man with mild to moderate erectile dysfunction: Efficacy at 8 and 12 hours postdose. Urology 71:686-692